International Cancer Research Conference
March 24-26, 2025 | Singapore
Causes of cancer
The uncontrolled proliferation of cancer cells is the fundamental abnormality that leads to the development of cancer. Cancer cells proliferate and divide uncontrollably, invading normal tissues and organs and eventually spreading throughout the body, instead of responding adequately to the signals that control normal cell behavior. Since cancer can arise from the aberrant multiplication of any of the body's cells, there are more than a hundred different types of cancer, each with its own unique behavior and therapeutic response. DNA damage and genomic instability are the primary causes of sporadic (non-familial) cancers. Inherited genetic mutations cause a small proportion of cancers. The majority of cancers are caused by environmental, lifestyle, or behavioral factors. Human cancer is generally not communicable, though oncoviruses and cancer germs can cause it.
- Physical and Chemical Agents
- Lifestyle: Diet and Exercise
- Infection and Inflammation
- Radiation
- Hormones
- Heredity
- Auto Immune Diseases
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
Seattle Children’s Hospital, United States
Michael Thompson
University of Toronto, Canada
Kaushala Prasad Mishra
Asian Association for Radiation Research (AARR), India
Mariola Wioletta Borowska
Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Andrea González Báez
Autonomous University of Nuevo Leon, Mexico
Qian Zhang
The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, ChinaSubmit your abstract Today
Title :
Patricia Tai, Saskatchewan Cancer Agency, Canada
Title :
Atif A Ahmed, Seattle Children’s Hospital, United States
Title :
Marika Crohns, Sanofi, Germany
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada